Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
Baljinder Singh, Candace M. Day, Sadikalmahdi Abdella, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 402-424
Open Access | Times Cited: 41

Showing 26-50 of 41 citing articles:

Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics
Brati Chakraborty, Gayatri Patel, Bandana Padhan, et al.
Applied Materials Today (2024) Vol. 41, pp. 102442-102442
Closed Access | Times Cited: 2
Intrathecal Immunoselective Nanopheresis for Alzheimer’s Disease: What and How? Why and When?
Manuel Menéndez‐González
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10632-10632
Open Access | Times Cited: 2
Novel nanoformulation for enhanced amphotericin B efficacy and sustained release using vetiver root cellulose nanofibers against Candida albicans
Richa Seth, Abha Meena, Amit Gosai, et al.
International Journal of Biological Macromolecules (2024), pp. 136555-136555
Closed Access | Times Cited: 2
Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer’s disease
Tanmoy Tantra, Abdul Rahaman T A, Nandini Nandini, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107912-107912
Closed Access | Times Cited: 2
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 1
Truncated mini LRP1 transports cargo from luminal to basolateral side across the blood brain barrier
Laura Fritzen, Katharina Wienken, Lelia Wagner, et al.
Fluids and Barriers of the CNS (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Saffron and its major constituents against neurodegenerative diseases: A mechanistic review
Sadaf Abdian, Sajad Fakhri, Seyed Zachariah Moradi, et al.
Phytomedicine (2024) Vol. 135, pp. 156097-156097
Closed Access | Times Cited: 1
QbD-based optimization and evaluation of chitosan-adorned nanostructured lipid carriers for nose-to-brain delivery of 17β-Estradiol in rat model of Alzheimer's disease
Akanksha Malaiya, Rameshroo Kenwat, Aanjaneya Mamgain, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105716-105716
Closed Access
Nanocrystals: a new herald for the management of Alzheimer’s disease
Viral Patel, Mithun Singh Rajput, Ayush Patel, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-14
Closed Access
Disease Modifying Monoclonal Antibodies and Symptomatic Pharmacological Treatment for Alzheimer’s Disease
Xiaoming Qi, Damir Nizamutdinov, Sheng‐Han Yi, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2636-2636
Open Access
Development of Thermosensitive Mucoadhesive Gel Based Encapsulated Lipid Microspheres as Nose-to-Brain Rivastigmine Delivery System
Nurafni Annisa Achmad, Rachmatya W. Tuna, Irfan Kurniawan, et al.
Langmuir (2024)
Closed Access
Association of CHAT Gene Polymorphism rs3793790 and rs2177370 with Donepezil Response and the Risk of Alzheimer’s Disease Continuum
Sun HongMei, Chao Lv, Xiaoxue Zhang, et al.
Clinical Interventions in Aging (2024) Vol. Volume 19, pp. 1041-1050
Open Access
Exosomes as Nanocarrier for Neurotherapy: Journey from Application to Challenges
Yogita Ale, Nidhi Nainwal
Journal of Drug Delivery Science and Technology (2024), pp. 106312-106312
Closed Access
Experience of using the combined drug Mioreol in patients with Alzheimer’s disease and mixed dementia
В. В. Захаров, N. N. Koberskaya
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 9, pp. 34-34
Closed Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Designed Cell-Penetrating Peptide Constructs for Inhibition of Pathogenic Protein Self-Assembly
Mona Kalmouni, Yujeong Oh, Waël Alata, et al.
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1443-1443
Open Access
Pharmacological management of Alzheimer’s disease: a current view
Júlia da Silva Grilo, Isabelle Campos Leite Domingues Borges, Julia Chaves Fahd, et al.
MOJ Gerontology & Geriatrics (2024) Vol. 9, Iss. 3, pp. 51-59
Open Access
Loliolide combats glutamate-induced neurotoxicity by oxidative stress through MAPK/Nrf2 pathway in hippocampal neuronal cells
Hyun‐Soo Kim, Jayeon Cheon, Kirinde Gedara Isuru Sandanuwan Kirindage, et al.
Algal Research (2024), pp. 103866-103866
Closed Access
Upcoming Nano and Conventional Drug Delivery Strategies for Alzheimer’s Disease
Nila Mary Varghese, Nandhakumar Sathyamoorthy, Praveen Thaggikuppe Krishnamurthy, et al.
(2024), pp. 313-332
Closed Access
Previous Page - Page 2

Scroll to top